Our quality approach
A finished peptide product is only as reliable as the supply chain behind it.
Raw materials are sourced through qualified manufacturing channels with traceable documentation. Applicable active pharmaceutical ingredients are sourced from manufacturers that meet the sourcing criteria required by our quality program.
Finished products are produced domestically in a controlled manufacturing environment, providing greater visibility into production, handling, documentation, and finished-product quality.
Each batch is supported by analytical documentation and a Certificate of Analysis from the manufacturer, covering applicable quality attributes such as identity, purity, and concentration.
We do not rely solely on manufacturer-supplied documentation. Manufacturer quality claims are independently verified through qualified third-party testing.
Finished batches undergo sterility testing, bacterial endotoxin testing, and applicable analytical quality testing. Required testing must be completed and reviewed before batch release.
A professional distribution model
Modern packaging can make almost any product appear legitimate. Professional labels, tamper-evident seals, QR codes, and a PDF called a “Certificate of Analysis” do not independently establish quality.
Our approach is built around documented sourcing, domestic finished-product manufacturing, independent verification, release testing, and controlled professional distribution.
Look past the packaging
Our standard
Medical professionals should not have to choose between access and accountability. Our goal is straightforward: provide physicians with a more transparent and controlled alternative to the largely unregulated direct-to-consumer peptide market.
Request Physician Access